Product Information

MIRABEGRON ER 25 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $9.3992 per EA under NDC 68180015109. Its NADAC has been published 110 times since Jul 17, 2024.

FDA first approved this application on Sep 28, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MIRABEGRON ER 25 MG TABLET

mirabegron
$9.3992per EA

Strength

25 mg/1

NDC

68180015109

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

MIRABEGRON

Approval Type

Generic (ANDA)

FDA Application

ANDA209485

FDA Approved

9/28/2022

TE Code

AB

On Market Since

4/19/2024

Pharmacological Classes

Adrenergic beta3-Agonists
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors
beta3-Adrenergic Agonist

Price Statistics

The NADAC for MIRABEGRON ER 25 MG TABLET has been published 110 times since Jul 17, 2024, and over the history we have for it it has risen 16.1%. The table below summarizes its recorded NADAC range and movement.

Current price$9.3992 per EA
All-time high$10.9668 (Sep 11, 2024)
All-time low$8.0956 (Jul 17, 2024)
52-week high$10.2877
52-week low$9.3185
Median price$9.8978
Average price$9.8168
Largest weekly change+35.5% (Aug 21, 2024)
Weeks tracked110
Tracking sinceJul 17, 2024

Price History

1W

+0.7%

1M

+0.7%

3M

+0.9%

6M

-1.9%

1Y

-8.6%

3Y

N/A

5Y

N/A

All

+16.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MIRABEGRON ER 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIRABEGRON ER 25 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $9.3992 per EA (NDC 68180015109), effective Aug 19, 2026.

How has the price of MIRABEGRON ER 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIRABEGRON ER 25 MG TABLET has risen 16.1%. It has been tracked across 110 weekly CMS publications since Jul 17, 2024.

What are the highest and lowest recorded NADAC prices for MIRABEGRON ER 25 MG TABLET?

Since Jul 17, 2024, the NADAC for MIRABEGRON ER 25 MG TABLET has ranged from a low of $8.0956 (Jul 17, 2024) to a high of $10.9668 (Sep 11, 2024), with a median of $9.8978 per EA.

Are there cheaper alternatives to MIRABEGRON ER 25 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIRABEGRON ER 25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MIRABEGRON ER 25 MG TABLET?

MIRABEGRON ER 25 MG TABLET (NDC 68180015109) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.